158 related articles for article (PubMed ID: 19231135)
1. Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients.
Akkad DA; Hoffjan S; Petrasch-Parwez E; Beygo J; Gold R; Epplen JT
J Autoimmun; 2009 Mar; 32(2):110-5. PubMed ID: 19231135
[TBL] [Abstract][Full Text] [Related]
2. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
3. Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population.
Heidari M; Behmanesh M; Sahraian MA
Immunol Invest; 2011; 40(3):279-89. PubMed ID: 21190413
[TBL] [Abstract][Full Text] [Related]
4. IL7RA polymorphisms and chronic inflammatory arthropathies.
O'Doherty C; Alloza I; Rooney M; Vandenbroeck K
Tissue Antigens; 2009 Nov; 74(5):429-31. PubMed ID: 19744146
[TBL] [Abstract][Full Text] [Related]
5. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
6. Risk alleles for multiple sclerosis in multiplex families.
D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
[TBL] [Abstract][Full Text] [Related]
7. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
8. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
[TBL] [Abstract][Full Text] [Related]
9. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.
Tajouri L; Ovcaric M; Curtain R; Johnson MP; Griffiths LR; Csurhes P; Pender MP; Lea RA
J Neurogenet; 2005; 19(1):25-38. PubMed ID: 16076630
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
[TBL] [Abstract][Full Text] [Related]
11. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
[TBL] [Abstract][Full Text] [Related]
13. Genomic regulation of CTLA4 and multiple sclerosis.
Palacios R; Comas D; Elorza J; Villoslada P
J Neuroimmunol; 2008 Oct; 203(1):108-15. PubMed ID: 18691768
[TBL] [Abstract][Full Text] [Related]
14. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
Stoevring B; Frederiksen JL; Christiansen M
Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
[TBL] [Abstract][Full Text] [Related]
15. [Association analysis of cytokine receptors' genes polymorphisms with clinical features of multiple sclerosis].
Kulakova OG; Bashinskaya VV; Tsareva EY; Boyko AN; Favorova OO; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10. Vyp. 2):10-15. PubMed ID: 28139605
[TBL] [Abstract][Full Text] [Related]
16. The genetics of multiple sclerosis: an update 2010.
Hoffjan S; Akkad DA
Mol Cell Probes; 2010 Oct; 24(5):237-43. PubMed ID: 20450971
[TBL] [Abstract][Full Text] [Related]
17. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
Goris A; Dobosi R; Boonen S; Nagels G; Dubois B
J Neuroimmunol; 2009 May; 210(1-2):113-5. PubMed ID: 19304328
[TBL] [Abstract][Full Text] [Related]
18. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis.
Fenoglio C; Galimberti D; Ban M; Maranian M; Scalabrini D; Venturelli E; Piccio L; De Riz M; Yeo TW; Goris A; Gray J; Bresolin N; Scarpini E; Compston A; Sawcer S
Neurosci Lett; 2006 Feb; 394(2):92-6. PubMed ID: 16257118
[TBL] [Abstract][Full Text] [Related]
19. Analysis of variation in the IL7RA and IL2RA genes in atopic dermatitis.
Hoffjan S; Beygo J; Akkad DA; Parwez Q; Petrasch-Parwez E; Epplen JT
J Dermatol Sci; 2009 Aug; 55(2):138-40. PubMed ID: 19523791
[No Abstract] [Full Text] [Related]
20. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
